| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-81 alpha chain precursor |
2.622 |
Evidence |
|
| CACNA1C |
CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1: Voltage-dependent L-type calcium chann |
HCN4 |
HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated chann |
2.622 |
Evidence |
|
| TRPA1 |
TRPA1, ANKTM1: Transient receptor potential cation channel subfamily A member 1 |
CACNA1F |
CACNA1F: Uncharacterized protein CACNA1F |
2.622 |
Evidence |
|
| BID |
BID: BH3-interacting domain death agonist |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
| TRPC6 |
TRPC6, TRP6: Short transient receptor potential channel 6 |
MFN1 |
MFN1: Mitofusin-1 |
2.622 |
Evidence |
|
| BCL2L11 |
BCL2L11, BIM: Bcl-2-like protein 11 |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
| CD1C |
CD1C: T-cell surface glycoprotein CD1c precursor |
HLA-C |
HLA-C, D6S204, HLA-JY3, HLAC: HLA class I histocompatibility antigen, Cw-17 alph |
2.622 |
Evidence |
|
| BMF |
BMF: Bcl-2-modifying factor |
BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
2.622 |
Evidence |
|
| TCF3 |
IPI00216911 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
2.622 |
Evidence |
|
| NULL |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-18 alpha chain precursor |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
2.622 |
Evidence |
|
| ELA3B |
ELA3B: Elastase-3B precursor |
SERPINB11 |
SERPINB11: Serpin B11 |
2.622 |
Evidence |
|
| SIM1 |
SIM1: Single-minded homolog 1 |
SIM2 |
SIM2: Single-minded homolog 2 |
2.622 |
Evidence |
|
| NFKB1 |
IPI00292537 |
CARD11 |
CARD11, CARMA1: Caspase recruitment domain-containing protein 11 |
2.622 |
Evidence |
|
| TCF21 |
TCF21, POD1: Transcription factor 21 |
PHTF1 |
PHTF1, PHTF: Putative homeodomain transcription factor 1 |
2.622 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
TTN |
TTN: Uncharacterized protein TTN (Fragment) |
2.622 |
Evidence |
|
| BBC3 |
BBC3, PUMA: Bcl-2-binding component 3 |
BCL2L14 |
BCL2L14, BCLG: Apoptosis facilitator Bcl-2-like 14 protein |
2.622 |
Evidence |
|
| MPDZ |
MPDZ, MUPP1: Multiple PDZ domain protein |
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
2.622 |
Evidence |
|
| RAB36 |
RAB36: Ras-related protein Rab-36 |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
2.622 |
Evidence |
|
| LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
CALR |
CALR, CRTC: Calreticulin precursor |
2.622 |
Evidence |
|
| BMPR1B |
BMPR1B: Bone morphogenetic protein receptor type IB precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.622 |
Evidence |
|
| IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
RYR2 |
RYR2: Ryanodine receptor 2 |
2.62 |
Evidence |
|
| CD5 |
CD5, LEU1: T-cell surface glycoprotein CD5 precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
2.62 |
Evidence |
|
| SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
2.62 |
Evidence |
|
| IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
2.62 |
Evidence |
|
| MS4A1 |
MS4A1, CD20: B-lymphocyte antigen CD20 |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
2.62 |
Evidence |
|
- 
- 
-